DarioHealth Ends a Successful Diabetes Awareness Month
Direct-to-consumer approach yields 4,000+ new sign-ups & higher user-engagement results
Dec 5, 2016
BOSTON, Dec. 5, 2016 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO), a leader in digital health and mobile health solutions, announced today that user-engagement metrics were higher during November 2016 when compared to the month of October 2016 due in part to Diabetes Awareness Month and new user-engagement strategies that were implemented.
DarioHealth's initiatives and efforts during November led to higher internet traffic due to, in our opinion, an increased amount of diabetes-related searches, especially on World Diabetes Day, when Google's "Doodle" commemorated the birthday of Sir Frederick Banting, the co-discoverer of insulin.
"During Diabetes Awareness Month, we welcomed thousands of new registrants. In the U.S. alone, we had over 4,000 new sign-ups," explained Erez Raphael, DarioHealth's Chief Executive Officer. "Our primary goal is to give members of our DarioHealth community the best user experience possible to deal with their diabetes. It is extremely encouraging and inspiring when we receive positive feedback. This is the ultimate vote of confidence and the results from Diabetes Awareness Month echo this. We continue to build on our success as we head towards 2017 and beyond," stated Mr. Raphael.
Key metrics that were analyzed were app downloads, email open rates and user promotions. In one promotion, Mr. Raphael explained how Dario customers sent in "Dario Selfies." These pictures are now being used in marketing materials, on social media, and can be viewed in DarioHealth's Corporate Presentation.
Mr. Raphael continued, "The Dario team was delighted not just by the number of photos we received, which in it of itself is a testament to the product, but also the diversity of the types of photos. Some users sent pictures from their homes, while others were out and about on daily activities, and a few were enjoying their vacation. This reinforces that Dario is everywhere."
About Diabetes Awareness Month
Diabetes Awareness Month was instituted as a response to the growing number of people diagnosed with diabetes. It is held annually in November, with World Diabetes Day occurring on November 14th in honor of the birthday of Sir Frederick Banting, a Canadian scientist who, along with his colleague Dr. Charles Best, discovered insulin. Nearly 30 million Americans have diabetes, per recent figures by the Centers for Disease Control and Prevention (CDC).
About DarioHealth Corp.
DarioHealth is a leader in digital health self-management solutions. DarioHealth delivers the ability to combine and analyze consumer health data to personalize treatment and advance medical knowledge. Dario's™ smart diabetes management solution is a platform for diabetes management that combines the Dario™ Blood Glucose Monitoring System all-in-one blood glucose meter, native smart phone app, website portal and a wide variety of treatment tools to support more proactive and better informed decisions by users living with diabetes, their doctors and healthcare systems. Having recently launched in the largest market in the world for glucose monitoring, U.S. sales are expected to have a significant impact on revenues and gross margins. With marketing clearance in Europe and the U.S., the Dario iOS mobile app recently launched with reimbursement in the United Kingdom, Australia, Israel, Italy, and Canada, and has also launched in New Zealand, Netherlands, Italy, and Belgium. For more information, visit http://mydario.investorroom.com/
Cautionary Note Regarding Forward-Looking Statements
This news release and the statements of representatives and partners of DarioHealth Corp. (the "Company") related thereto contain or may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements that are not statements of historical fact may be deemed to be forward-looking statements. Without limiting the generality of the foregoing, words such as "plan," "project," "potential," "seek," "may," "will," "expect," "believe," "anticipate," "intend," "could," "estimate" or "continue" are intended to identify forward-looking statements. For example, when the Company describes its growth potential, its expectations for 2017 and beyond, the opportunities afforded to it by its direct to consumer model, and says that U.S. sales are expected to have a significant impact on the Company's revenues and gross margins, it is using forward-looking statements. Readers are cautioned that certain important factors may affect the Company's actual results and could cause such results to differ materially from any forward-looking statements that may be made in this news release. Factors that may affect the Company's results include, but are not limited to, regulatory approvals, product demand, market acceptance, impact of competitive products and prices, product development, commercialization or technological difficulties, the success or failure of negotiations and trade, legal, social and economic risks, and the risks associated with the adequacy of existing cash resources. Additional factors that could cause or contribute to differences between the Company's actual results and forward-looking statements include, but are not limited to, those risks discussed in the Company's filings with the U.S. Securities and Exchange Commission. Readers are cautioned that actual results (including, without limitation, the timing for and results of the Company's commercial and regulatory plans for Dario™) may differ significantly from those set forth in the forward-looking statements. The Company undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law.
DarioHealth Corporate and Media Contact
DarioHealth Investor Relations Contact
Rob Fink / Brett Maas
+1-646-415-8972 / +1-646-536-7331
SOURCE DarioHealth Corp.